Jury Awards $70 Million in Talcum Powder Lawsuit
Posted On behalf of Pfeifer Morgan & Stesiak on Nov 15, 2016 in Product Injury
Late last month, a woman from California was awarded $70 million in her lawsuit against Johnson & Johnson over the company's Baby Powder product, which contains talcum powder.
The woman claimed that using the product for many years caused her to develop ovarian cancer. The jury ruled that Johnson & Johnson was aware talcum powder increased the risk of ovarian cancer and failed to provide adequate warning to doctors and consumers.
Approximately 2,000 women have filed similar lawsuits, but this is only the third talcum powder case to result in a monetary award.
The first case to result in a monetary award ended in February, when a St. Louis jury awarded the family of a woman killed by ovarian cancer a total of $72 million in compensation.
The second case concluded in May, when a jury awarded $55 million to a South Dakota ovarian cancer survivor. The jury ruled that she developed ovarian cancer because she frequently used talcum powder products from Johnson & Johnson.
Despite the lawsuits, Johnson & Johnson claims studies show there is no link or a negligible one between talcum powder and ovarian cancer.
However, there are many other studies that have found a significant link between the use of talcum powder and ovarian cancer. According to a 1982 study, the use of talcum powder for feminine hygiene during ovulation increased the risk of ovarian cancer by 92 percent.
Another study in 2013 revealed that talcum powder use near the genitals increased the risk of ovarian cancer by as much as 30 percent.
If you or a loved one developed ovarian cancer after using Johnson & Johnson's talcum powder products, you may be able to file a talcum powder lawsuit to obtain compensation.
Our product liability lawyers will review your claim for free and inform you of your legal options. We will not charge legal fees unless we achieve a favorable resolution of your claim.
Contact us right now by calling (844) 678-1800 or live chatting with a representative.